Barcode
Nazareth
About Barcode
Providing a solution to one of the largest challenges in RNA therapeutics – selective delivery to target cells Exciting advancements in the biotech field are marking RNA therapies as promising candidates for the treatment of diseases that were considered untreatable thus far. However, the largest challenge in developing innovative RNA therapeutics is protecting them from degradation and delivering these molecules to the selected target tissue or cell. Barcode is enabling RNA therapeutics and vaccines by developing and testing new delivery formulations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2019)
- Website: barcode-nano.com
- Phone: +972 4.6098600
Industries & Categories
Biopharma, Biotechnology, Health Care, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/barcode-149116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.